on day 0

on day 0. in cancer progression. Similar results were observed in the MMTV-PyMT transgenic BC mouse model, along with a decrease in tumor metastasis, emphasizing the potential immune-independent effects of PIK3C inhibition. Finally, analysis of BC patient cohorts and TCGA data sets identified f-PIK3C (protein and mRNA levels) as an Continue Reading

Posted In LPL